UPDATE : Monday, December 16, 2019
상단여백
Dongwha could lose ₩60 billion sales as GSK ends deal by Lee Han-soo 2019-09-20 14:28
Novo Nordisk releases trial result for basal insulin analog injection by Lee Han-soo 2019-09-20 12:27
Multinational pharmaceuticals continue to increase R&D spending in Korea by Lee Han-soo 2019-09-19 17:15
Hanmi unveils strong diabetes pipeline at EU meet by Lee Han-soo 2019-09-19 15:30
‘Galderma Korea ran background checks on unionized workers’ by Jeong Sae-im 2019-09-19 15:18
라인
Takeda Korea labor union to ask Japanese headquarters about restructuring by Kim Yun-mi 2019-09-19 14:11
Chong Kun Dang releases trial result for diabetes treatment by Lee Han-soo 2019-09-19 14:11
Indian biosimilar of rituximab to undergo test in Korea by Lee Hye-seon 2019-09-19 10:31
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo by Lee Han-soo 2019-09-18 15:48
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia by Lee Han-soo 2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer? by Kim Yun-mi 2019-09-18 11:36
Hanmi spurs new immunotherapy development through open innovation by Lee Han-soo 2019-09-17 18:14
‘Lundbeck to work with parliament to prevent suicide in Korea’ by Kim Yun-mi 2019-09-17 15:19
Shinpoong's malaria treatment expands global presence by Lee Han-soo 2019-09-17 15:13
SK Bioscience to export influenza vaccine to Asian countries by Lee Han-soo 2019-09-17 11:27
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma by Kim Yun-mi 2019-09-16 16:20
'Roche Korea to put patient accessibility first' by Lee Han-soo 2019-09-16 15:41
GC’s Hunter syndrome drug to get priority screening in China by Lee Han-soo 2019-09-16 13:56
GSK’s chronic hand eczema treatment faces local competition by Lee Han-soo 2019-09-12 07:22
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
여백
여백
여백
Back to Top